The changes in metabolic pathways mediated by dysregulated Kla modifications in GI tumors were consistent with a previous conclusion in HCC.[34] In addition to metabolic alterations, multiple Kla sites in proteins involved in RNA regulation, genome stability, and proteasome are also dysregulated in GI cancer. Here, KL is linked to digestive system neoplasm.